Skip to main content
Signal8

Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Founded in 2000 and headquartered in Cardiff, United Kingdom, the company was formerly known as Midatech Pharma plc until its rebranding in March 2023. Its research and development efforts are focused on addressing significant unmet medical needs, including familial adenomatous polyposis, non-muscle invasive bladder cancer, Type 1 diabetes, and a spectrum of rare or orphan brain cancers. The company's primary drug candidate, Tolimidone, a selective activator of the lyn kinase enzyme, is currently undergoing Phase II clinical trials for the management of Type 1 diabetes. Additionally, Biodexa is progressing MTX110 through Phase I studies as an investigational treatment targeting specific challenging brain malignancies such as diffuse intrinsic recurrent glioblastoma, diffuse midline glioma, and medulloblastoma. Beyond its direct drug pipeline, Biodexa Pharmaceuticals also provides a suite of advanced drug delivery platforms designed to optimize therapeutic efficacy. These include Q-Sphera, a microtechnology utilizing polymer microspheres for controlled, sustained release of medications; MidaSolve, an oligosaccharide nanotechnology that facilitates the solubilization of drugs, enabling their direct and localized administration into tumor sites; and MidaCore, which employs gold nanoparticles for precise targeting of diseased areas, allowing for the delivery of either chemotherapeutic or immunotherapeutic agents. The company has established strategic collaboration agreements with pharmaceutical industry leaders Janssen and Melior.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc

NASDAQ:BDRXHealthcare
-12.05%$3.43
AH$3.15-8.16%vs close
Mkt Cap$3.53M
Float249K
O/S1.03M
Vol
$ Vol
RVOL
Inst Own-
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$8.37M
Total Assets$24.32M
Free Cash Flow-$7.23M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$82K
Total Equity$15.25M
Shares Outstanding
Short Interest
Split History10 splits · 10 reverse
2-year cumulative
1:4,000,000Over cap

Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period

  1. 1:8Reverse split
    Oct 26, 20268 shares → 1
  2. 1:10,000Reverse split
    Jul 29, 202610,000 shares → 1
  3. 1:5Reverse split
    Apr 6, 20265 shares → 1
  4. 1:10Reverse split
    Jul 31, 202510 shares → 1
  5. 1:25Reverse split
    Oct 4, 202425 shares → 1
  6. 1:80Reverse split
    Jul 5, 202380 shares → 1
  7. 1:4Reverse split
    Mar 27, 20234 shares → 1
  8. 1:5Reverse split
    Sep 26, 20225 shares → 1
Balance Sheet Details
Assets$24.32M
Liabilities$9.06M
Accounts Receivable$297K
Accounts Payable$130K
Inventory$0
PP&E (Net)$122K
Goodwill$0
Intangible Assets$7.55M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$0$0$510K$937K$774K$460K$903K$2.6M$1.33M$1.77M$1.84M$210K$197K$0
YoY Growth---45.5%20.9%68.5%-49.1%-65.2%96.0%-25.2%-3.8%775.8%6.8%--
Cost of Revenue$248K$7.28M$5.45M$6.85M$6.24M$8.13M$10.51M$12.54M$11.16M$10.36M$94K$0$0$0
Gross Profit-$248K-$7.28M-$4.94M-$5.91M-$5.46M-$7.67M-$9.61M-$9.94M-$9.83M-$8.58M$1.75M$210K$197K$0
Gross Margin---967.5%-631.2%-705.2%-1669.1%-1063.6%-382.9%-742.2%-484.3%94.9%100.0%100.0%-
Research and Development$5M$7.28M$5.45M$6.85M$6.24M$21.63M$10.51M$12.54M$13.17M$10.36M$11.67M$7.29M$3.81M$2.21M
Selling, General, and Administrative$6.48M$5.08M$5.82M$6.09M$3.95M$6.64M$5.58M$5.89M$5.94M$4.35M$3.6M$5.67M$2.42M$3.16M
Other-$647K-$7.33M-$5.47M-$6.88M-$6.27M-$5.08M-$11.18M$0$0$0$0$0$0$0
Total Operating Expenses$10.83M$5.04M$5.8M$6.06M$3.92M$23.2M$4.91M$5.89M$7.42M$2.78M$16.86M$13.19M$6.23M$5.37M
Operating Income (EBIT)-$11.08M-$12.33M-$10.74M-$11.97M-$9.38M-$30.87M-$15.16M-$15.83M-$15.78M-$12.93M-$13.52M-$10.34M-$6.03M-$5.37M
Operating Margin---2103.4%-1277.8%-1210.7%-6717.2%-1679.2%-609.6%-1190.7%-729.6%-734.0%-4914.0%-3060.5%-
Interest Expense$92K$0$55K$71K$59K$46K$130K$787K$146K$0$0$216K$332K$0
Interest Income$117K$3K$111K$39K$0$1K$11K$3K$20K$122K$64K$11K$515K$746K
Other Income (Expense)$2.58M$4.31M$709K$595K$1.2M-$576K$529K-$784K-$1.6M$1.69M$2.26M-$205K-$515K-$746K
Income Before Tax (EBT)-$8.5M-$8.01M-$10.03M-$11.37M-$8.18M-$31.45M-$14.64M-$16.61M-$17.38M-$11.24M-$15.05M-$13.18M-$6.54M-$6.12M
Income Tax Expense-$138K-$335K-$544K-$1.11M-$866K-$1.72M-$2.39M-$2.72M-$1.69M-$2.98M-$1.52M-$1.36M-$1.07M-$765K
Net Income-$8.37M-$7.68M-$9.49M-$10.26M-$7.32M-$29.73M-$13.51M-$13.89M-$15.68M-$8.26M-$13.53M-$11.82M-$5.47M-$5.35M
Net Income Margin---1858.0%-1095.3%-944.6%-6469.1%-1496.3%-535.0%-1183.5%-465.7%-734.5%-5619.1%-2778.2%-
Supplementary Data
EPS-400.00-3705.65-69640.00-4770680.00-4661590.00-33209775.00-35095575.00-292803790.00-397196150.00-740868715.00-536944425.00-1577747295.00-229264380.00-216922555.00
Diluted EPS-400.00-3705.65-69640.00-4770680.00-4661590.00-33209775.00-35095575.00-292803790.00-397196150.00-740868715.00-536944425.00-1577747295.00-229264380.00-216922555.00
Weighted Average OS21,9441,98112611000000000
EBITDA-$10.83M-$11.99M-$9.59M-$10.84M-$7.58M-$29.77M-$12.78M-$14.34M-$14.21M-$7.1M-$14.06M-$12.54M-$5.7M-$5.11M
EBITDA Margin---1879.5%-1157.7%-979.1%-6477.8%-1415.6%-552.3%-1072.7%-400.8%-762.9%-5959.9%-2893.2%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$11.41M$2.24M$8M$3.8M$13.48M$10.11M$14.64M$3.14M$17.69M$23.59M$21.67M$40.63M$3.2M$290K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$11.41M$2.24M$8M$3.8M$13.48M$10.11M$14.64M$3.14M$17.69M$23.59M$21.67M$40.63M$3.2M$290K
Accounts Receivable$297K$958K$943K$441K$44K$127K$2.43M$119K$2.99M$1.91M$1.32M$253K$214K$2.01M
Inventory$0$0-$943K$0$0$0$0$0$1.26M$1.09M$615K$0$0$0
Other Current Assets$0$0$943K$1.54M$1.43M$1.84M$1.13M$4.08M$2.12M$2.5M$2.72M$1.43M$1.98M$1
Total Current Assets$16.64M$11.8M$9.42M$6.28M$15.76M$12.43M$18.41M$7.53M$24.9M$29.88M$27.24M$42.38M$5.49M$2.39M
Long-Term Assets
Property, Plant & Equipment Net$122K$434K$765K$1.11M$1.54M$726K$2.89M$2.66M$3.39M$3.71M$2.66M$2.03M$916K$1.91M
Goodwill$0$0$0$0$0$0$3.07M$3.07M$18.01M$19.41M$16.69M$3.07M$0$0
Intangible Assets$7.55M$7.57M$3.94M$8K$0$0$13.52M$13.51M$19.03M$22.35M$38.7M$14.47M$5K$4K
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$16K$536K
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$3.52M$628K$623K$600K$519K$569K$508K$0
Total Long-Term Assets$7.67M$8M$4.71M$1.12M$1.54M$726K$22.99M$19.87M$41.06M$46.07M$58.57M$20.15M$1.45M$2.45M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$24.32M$19.8M$14.13M$7.4M$17.3M$13.15M$41.4M$27.39M$65.95M$75.96M$85.81M$62.52M$6.93M$4.84M
Liabilities
Current Liabilities
Accounts Payable$130K$947K$421K$454K$650K$452K$971K$383K$3.04M$4.38M$3.06M$1.31M$699K$1.23M
Short-Term Debt$0$0$0$0$0$143K$240K$386K$431K$679K$498K$608K$1.61M$4.96M
Current Income Tax Payable$0$67K$83K$103K$75K$42K$115K$0$0$0$0$0$0$0
Current Unearned Revenue$764K$1.97M$0$264K$0$91K$0$0$0$0$0$0$0$1.15M
Other Current Liabilities$4.65M$1.23M$5.67M$517K$890K$2.17M$3.7M$1.06M$3.54M$4.74M$4.38M$841K$626K$3.69M
Total Current Liabilities$8.2M$6.75M$7.46M$2.55M$2.47M$4M$7.59M$3.31M$11.21M$12.52M$12.19M$3.79M$3.08M$11.03M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$6.38M$957K$8.25M$2.1M$1.93M$1.99M$2.79M$4.72M
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$863K$1.75M$0$0-$628$67K$0$221K$0$0$8.77M$474K$0$0
Total Long-Term Liabilities$863K$1.91M$395K$620K$830K$147K$7.6M$1.41M$8.29M$2.17M$10.79M$2.47M$2.84M$4.89M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$1
Total Liabilities$9.06M$8.65M$7.86M$3.17M$3.3M$4.15M$15.19M$4.72M$19.49M$14.69M$22.98M$6.26M$5.91M$15.93M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$18.86M$8.96M$1.59M$145K$132K$84K$31K$4K$4K$3K$3K$1K$0$0
Retained Earnings-$137.51M-$201.55M-$193.97M-$181.34M-$171.24M-$164.05M-$133.77M-$120.21M-$100.03M-$79.2M-$52.46M-$39.15M-$27.33M-$37.45M
Comprehensive Income & Other$1.59M$71.02M$82.43M$71.02M$71.02M$73.32M$71.68M$71.95M$75.55M$77.21M$72.88M$53.02M$190K$298K
Other Stockholders' Equity$133.9M$203.74M$198.65M$185.43M$185.12M$172.96M$159.95M$142.89M$146.49M$140.46M$115.28M$95.41M$28.35M$26.36M
Total Equity$15.25M$11.15M$6.27M$4.24M$14.01M$9M$26.21M$22.68M$46.46M$61.27M$62.82M$56.26M$1.02M-$11.09M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$24.32M$19.8M$14.13M$7.4M$17.3M$13.15M$41.4M$27.39M$65.95M$75.96M$85.81M$62.52M$6.93M$4.84M
Supplementary Data
Total Debt$82K$974K$622K$836K$1.03M$348K$8.15M$1.68M$8.77M$2.89M$2.61M$2.6M$4.51M$9.85M
Net Debt-$11.33M-$1.26M-$7.38M-$2.96M-$12.45M-$9.76M-$6.49M-$1.46M-$8.92M-$20.7M-$19.06M-$38.03M$1.31M$9.56M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$8.55M-$7.68M-$9.49M-$10.26M-$7.32M-$29.73M-$13.51M-$20.14M-$21.52M-$27.01M-$13.53M-$11.82M-$5.47M-$5.35M
Depreciation & Amortization$248K$340K$379K$460K$540K$1.63M$1.72M$1.49M$1.56M$5.83M$986K$430K$330K$260K
Deferred Income Tax-$141K-$335K-$544K-$1.11M$628K$17.69M-$2.39M$0$0$0$1.92M$0$0$0
Stock-Based Compensation$228K$379K$38K$165K$119K-$541K-$46K$0$0$0$228K$0$0$0
Changes in Working Capital:
  Accounts Receivable$3.45M-$8.01M$489K$9K-$653K$661K$971K$1.38M-$1.3M-$324K-$2.06M$1.02M-$592K-$226K
  Inventory$0$0$0$0$0$0$0$465K-$271K-$318K-$83K$0$0$0
  Accounts Payable-$1.2M$0$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital$0$3M-$555K$687K-$174K-$2.75M$1.44M$221K$0$0$0$0$0$0
Total Working Capital Change$2.25M-$5.01M-$66K$697K-$827K-$2.09M$2.41M$2.07M-$1.57M-$642K-$2.15M$1.02M-$592K-$226K
Other Non-Cash Items-$1.26M-$4.13M$532K$608K-$1.2M$576K$3.12M-$1.44M$4.17M$4.29M-$2.18M$3.06M-$209K$782K
Net Cash from Operating-$7.23M-$16.43M-$9.15M-$9.44M-$8.05M-$12.46M-$8.69M-$18.02M-$17.36M-$17.53M-$16.64M-$7.31M-$5.94M-$4.31M
Investing Activities
Capital Expenditures-$906K-$12K-$35K-$83K-$429K-$280K-$427K-$327K-$947K-$1.8M-$1.24M-$1.38M-$63K-$320K
Acquisitions$24K$0$0$0$0$0-$1.27M$0$0$0-$886K$154K$0$0
Purchases of Investments$0$0$0$0$0$0-$3.42M$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$3.54M$0$0$0$0$0$0$0$0
Other Investing Activities$0-$789K-$320K-$212K$56K$193K$11K$12.44M-$1.02M$194K$67K$11K-$4K-$79K
Net Cash from Investing-$882K-$801K-$355K-$295K-$372K$3.45M-$5.1M$12.12M-$1.97M-$1.61M-$2.05M-$1.22M-$67K-$399K
Financing Activities
Debt Repaid$933K$249K$252K$239K$288K$8.28M-$5.17M$7.8M-$6.28M$228K$221K-$729K-$1.41M-
Common Stock Issuance$18.02M$11.14M$13.97M$326K$12.11M$13.05M$18.9M$0$7.67M$0$0$45.36M$7.77M$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$20K-$318K-$17K-$24K-$20K-$638K$1.03M-$787K-$182K$20.76M-$7K-$129K-$145K-$167K
Net Cash from Financing$17.11M$11.47M$13.7M$63K$11.8M$4.13M$25.1M-$8.67M$13.77M$20.44M-$293K$45.96M$9.03M-$167K
Forex Effect$339K$0$0$0-$11K$350K$198K$25K-$346K$624K$31K$0$0$5.05M
Net Change in Cash$9.34M-$5.76M$4.2M-$9.68M$3.36M-$4.53M$11.5M-$14.55M-$5.9M$1.92M-$18.96M$37.43M$3.02M$178K
Supplementary Data
Operating Cash Flow-$7.23M-$16.43M-$9.15M-$9.44M-$8.05M-$12.46M-$8.69M-$18.02M-$17.36M-$17.53M-$16.64M-$7.31M-$5.94M-$4.31M
Capital Expenditure-$3K-$1.04M-$352K-$83K-$429K-$280K-$427K-$327K-$947K-$1.8M-$1.24M-$1.38M-$63K-$320K
Free Cash Flow-$7.23M-$17.47M-$9.5M-$9.53M-$8.48M-$12.74M-$9.12M-$18.35M-$18.3M-$19.34M-$17.88M-$8.69M-$6.01M-$4.63M
Cash at Beginning$2.08M$8M$3.8M$13.48M$10.11M$14.64M$3.14M$17.69M$23.59M$21.67M$40.63M$3.2M$178K$0
Cash at End$11.41M$2.24M$8M$3.8M$13.48M$10.11M$14.64M$3.14M$17.69M$23.59M$21.67M$40.63M$3.2M$178K